Global Immunodiagnostic Reagent Market Outlook 2022

Using the method of immune diagnosis, reagents are used in vitro for the diagnosis, detection and epidemiological investigation of human diseases.

The global Immunodiagnostic Reagent market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Immunodiagnostic Reagent volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Immunodiagnostic Reagent market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Immunodiagnostic Reagent Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Electrochemiluminescence
Colloidal Gold
Chemiluminescence
Isotope

Segment by Application
Infectious Disease
Drug Testing
Tumor
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Roche
Abbott
BD
Shanghai Kehua Bio-engineering
Livzon
Beijing Leadman Biochemis
Diametra
BioMerieux
DiaSorin
Bio-Rad
Eiken Chemical
Grifols
PerkinElmer
Quest Diagnostics